Ongoing Research: Effects of VLCD and Drug Treatment for Obesity. (Protocol I. Protocol F. CONCI)

by Cassidy Older | Mar 26, 2024 | Research

Welcome to CONCI

by Cassidy Older | Feb 28, 2023 | CONCI Updates

For over 45 years, CONCI has remained a staple in the Ohio weight loss community. Why? Because our programs work! A group of licensed medical professionals with specialized education in obesity management design every program. Our expert team of physicians, registered...

Five-year Maintenance Results of an Obesity Drug Following a Very Low Calorie Diet (VLCD) Presented at Obesity Week, 2013

by Cassidy Older | Mar 12, 2013 | Research

J Loper, R Lutes, T Broyles, R May, E Baltes.

Naltrexone SR/Bupropion SR Combination Therapy Reduces Total and Visceral Adiposity in Overweight and Obese Subjects in the COR-1 Study. American Diabetes Association, 2011.

by Cassidy Older | Mar 12, 2011 | Research

Smith S, T Church, J Goohas, C Griffin, W Harper, D Krieger, J Loper, Smudahar, C Woodrugg, M Guittalauria, E Henry, D Kim, E Dunayevich.

Naltrexone SR/Bupropion SR Therapy Reduced Body Weight and HgbA1C in Overweight/Obese Women with Type 2 Diabetes. American Diabetes Association, 2011.

by Cassidy Older | Mar 12, 2011 | Research

P Hollander, J Loper, L Mignon, C Burns, R Harris-Collzao, D Kim.